Sign in

CIK 0001563665

  • Non-accelerated filer
  • Smaller reporting company

Harvard Apparatus Regenerative Technology, Inc.

Sign in to watch
Ticker
HRGN
Exchange
OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
455210462
Phone
+1 774-233-7300
Business address
84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746
Former names
Biostage, Inc.
  1. 4 Open-market buy Chief Financial Officer bought 5,000 shares at an average $1.56 ($7,775)
  2. 4 Open-market buy President and CEO bought 10,000 shares at $1.56 ($15,600)
  3. 4/A Open-market buy Director bought 18,000 shares at $1.36 ($24,401)
  4. 4 Open-market buy Director bought 18,000 shares at $1.36 ($24,401)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Chief Medical Officer bought 2,393 shares at $2.01 ($4,817)
  16. 4 Open-market buy Chief Medical Officer bought 10,000 shares at $3.01 ($30,052)
  17. 4 Open-market buy Director bought 9,000 shares at $2.95 ($26,525)
  18. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $1.70 ($17,000)
  19. 4 Open-market buy President and CEO bought 10,000 shares at $1.79 ($17,900)
  20. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $1.56 ($15,600)

Page 9 of 12 · 235 filings